Skip to main content
CGNT
NASDAQ Technology

Cognyte Reports Strong Q1 FY27 Results with Double-Digit Revenue Growth, 41.5% Non-GAAP Operating Income Increase, and Reiterates Full-Year Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$9.18
Mkt Cap
$849.171M
52W Low
$6.29
52W High
$12.31
52W Position info
46% above low
Off High info
25% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

CGNT sits 46% above its 52-week low of $6.29.

Summary

Cognyte Software announced strong Q1 FY27 financial results, featuring 10.4% revenue growth and a 41.5% increase in non-GAAP operating income, while reiterating its positive full-year outlook and continuing its share buyback program.


Key Events · Earnings and Guidance · CGNT

  • Strong Q1 FY27 Financial Performance

    Revenue grew 10.4% year-over-year to $105.5 million. Non-GAAP operating income increased 41.5% to $10.7 million, and Adjusted EBITDA rose 31.5% to $13.6 million, demonstrating strong profitability growth.

  • Reiterated Full-Year FY27 Outlook

    The company maintained its guidance for fiscal year 2027, projecting approximately 12% year-over-year revenue growth to $448 million and about 40% Adjusted EBITDA growth to $68 million at the midpoint.

  • Continued Share Repurchase Program

    Cognyte repurchased approximately 1 million ordinary shares for an aggregate purchase price of $8.2 million during Q1 FY27. Since November 2024, the company has repurchased $35 million out of $60 million authorized.

  • Strong Recurring Revenue and Billings Growth

    Recurring revenue increased 10.0% to $51.9 million, representing 49.2% of total revenue. Billings grew 31.2% to $102.7 million compared to the same period last year.


Analysis · CGNT · Technology

Cognyte Software reported robust first-quarter fiscal year 2027 results, demonstrating significant operational improvements with double-digit revenue growth and even stronger profitability growth. The company's decision to reiterate its full-year guidance, which projects substantial revenue and Adjusted EBITDA growth, signals management's confidence in continued momentum. Additionally, the ongoing share repurchase program indicates a commitment to returning capital to shareholders.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 38.5% of the 1020 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CGNT was trading at $9.18 on NASDAQ in the Technology sector, with a market capitalization of approximately $849.2M. The 52-week trading range was $6.29 to $12.31. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CGNT - Latest Insights

CGNT
Oct 21, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $8.64
Real-time Price: $9.76 info
Change: +$1.12 (+13%) info
Market Cap: $735.129M info
CGNT
Sep 30, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $9.76 info
Change: +$1.26 (+15%) info
Market Cap: $735.129M info
CGNT
Sep 22, 2026, 8:10 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $8.75
Real-time Price: $9.76 info
Change: +$1.01 (+12%) info
Market Cap: $735.129M info
CGNT
Sep 15, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $7.92
Real-time Price: $9.76 info
Change: +$1.84 (+23%) info
Market Cap: $735.129M info
CGNT
Sep 09, 2026, 7:49 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.19
Real-time Price: $9.76 info
Change: +$0.570 (+6%) info
Market Cap: $735.129M info